Good Pharmacovigilance Practice in Paediatrics: An Overview of the Updated European Medicines Agency Guidelines
Paediatr Drugs
.
2019 Oct;21(5):317-321.
doi: 10.1007/s40272-019-00350-w.
Authors
Janet Sultana
1
,
Cosimo Zaccaria
2
,
Roberto de Lisa
3
,
Francesco Rossi
4
5
,
Annalisa Capuano
4
5
,
Carmen Ferrajolo
6
7
Affiliations
1
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
2
Signal and Incident Management Service, Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.
3
Paediatric Medicines Office Product Development Scientific Support Department, European Medicines Agency, Amsterdam, The Netherlands.
4
Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli", Naples, Italy.
5
Campania Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy.
6
Department of Experimental Medicine, Pharmacology Division, University of Campania "L. Vanvitelli", Naples, Italy. Carmen.ferrajolo@unicampania.it.
7
Campania Regional Centre of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy. Carmen.ferrajolo@unicampania.it.
PMID:
31378846
DOI:
10.1007/s40272-019-00350-w
No abstract available